UCLA Health

Datopotamab Deruxtecan Improved Progression-Free Survival Versus Chemotherapy in Patients with Previously Treated Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial

Retrieved on: 
월요일, 10월 23, 2023

Median PFS was 4.4 months in patients treated with datopotamab deruxtecan compared to 3.7 months with docetaxel.

Key Points: 
  • Median PFS was 4.4 months in patients treated with datopotamab deruxtecan compared to 3.7 months with docetaxel.
  • Results also showed a confirmed objective response rate (ORR) of 26.4% in patients treated with datopotamab deruxtecan compared to an ORR of 12.8% in patients treated with docetaxel.
  • Median PFS was 5.6 months in patients treated with datopotamab deruxtecan compared to 3.7 months in those treated with docetaxel.
  • At the March 29, 2023 data cut-off, 52 patients remained on treatment with datopotamab deruxtecan and 17 remained on docetaxel.

New Data Presented at CHEST 2023 Demonstrate the Clinical Utility of Veracyte’s Envisia Genomic Classifier for Patients with Interstitial Lung Disease

Retrieved on: 
목요일, 10월 12, 2023

(Nasdaq: VCYT) today announced that new data presented at the American College of Chest Physicians (CHEST) Annual Meeting 2023 demonstrate the clinical utility of the company’s Envisia Genomic Classifier, which is used by physicians to improve diagnostic and prognostic confidence of interstitial lung diseases (ILDs).

Key Points: 
  • (Nasdaq: VCYT) today announced that new data presented at the American College of Chest Physicians (CHEST) Annual Meeting 2023 demonstrate the clinical utility of the company’s Envisia Genomic Classifier, which is used by physicians to improve diagnostic and prognostic confidence of interstitial lung diseases (ILDs).
  • The studies also underscore the challenge of identifying usual interstitial pneumonia (UIP) in patients being evaluated for ILD.
  • The studies presented at the CHEST Annual Meeting show that adding the Envisia Genomic Classifier to the diagnostic process can improve the ability to detect UIP.
  • For patients with indeterminate HRCT results, adding the Envisia Genomic Classifier more than doubled the UIP diagnostic yield to 49%.

Mindfulness Meditation Application Market to grow by USD 1.48 billion from 2022 to 2027 | Growth Driven by the rising cases of mood disorders- Technavio

Retrieved on: 
월요일, 10월 9, 2023

The potential growth difference for the mindfulness meditation application market from 2022rom to 2027 is USD 1.48 billion.

Key Points: 
  • The potential growth difference for the mindfulness meditation application market from 2022rom to 2027 is USD 1.48 billion.
  • Get deeper insights into the market size, current market scenario, future growth opportunities, major growth driving factors, the latest trends, and much more.
  • Buy the full report here
    The rising cases of mood disorders are key factors driving market growth.
  • Increased demand may be stimulated by the growing acceptance of mindful meditation techniques as a powerful treatment for mood disorders.

Ambrx to Host KOL Event Discussing ARX517 Data Presented at ESMO Congress 2023

Retrieved on: 
화요일, 9월 26, 2023

SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that it will host an in-person key opinion leader (KOL) event during the European Society for Medical Oncology (ESMO) Congress 2023.

Key Points: 
  • SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that it will host an in-person key opinion leader (KOL) event during the European Society for Medical Oncology (ESMO) Congress 2023.
  • The event will take place on Sunday, October 22, 2023 from 8:00pm – 10:00pm CEST (2:00pm – 4:00pm ET) at the Santo Mauro Hotel in Madrid, Spain.
  • Discussions will feature preliminary safety, efficacy, and pharmacokinetic (PK) data from APEX-01 ( NCT04662580 ), a first-in-human study evaluating ARX517 in prostate cancer patients, which will be presented for the first time at ESMO 2023.
  • A replay of the event will be available on the Investor Relations section of the Ambrx website ( www.ambrx.com ) after the event.

The Beryl Institute Announces 7 New Strategic Advisory Board Members

Retrieved on: 
수요일, 9월 13, 2023

NASHVILLE, Tenn. , Sept. 13, 2023 /PRNewswire-PRWeb/ -- Strengthening its dedication to the growth of the patient experience across the continuum of care, The Beryl Institute welcomes new members to its Strategic Advisory Board. The Strategic Advisory Board serve as a key advisor to operations of The Beryl Institute. The board provides practical advice on strategy, growth opportunities and future plans, along with valuable insights into market and industry trends.

Key Points: 
  • NASHVILLE, Tenn. , Sept. 13, 2023 /PRNewswire-PRWeb/ -- Strengthening its dedication to the growth of the patient experience across the continuum of care, The Beryl Institute welcomes new members to its Strategic Advisory Board .
  • The Strategic Advisory Board serve as a key advisor to operations of The Beryl Institute.
  • Joining the previous 11 members, new members of the Strategic Advisory Board include:
    Karen Grimley, PhD, Chief Nursing Executive and Assistant Dean, UCLA Health and UCLA School of Nursing
    -Jennifer Purdy, LCSW, CPXP, Executive Director, CX Tools and Implementation Veterans Experience Office, Dept.
  • of Veterans Affairs
    "We are honored to engage these new members and the diversity of voices they represent - from patients, professionals and executives around the world - to our Strategic Advisory Board," said Jason Wolf, Ph.D., CPXP, President and CEO of The Beryl Institute.

Nectar Life Sciences, the Health Technology Company Behind the First Hybrid, Vertically-Integrated Allergy Care Platform, Opens First Nectar Allergy Center in New York City

Retrieved on: 
월요일, 8월 28, 2023

Nectar Life Sciences , the trusted health technology company behind the first hybrid, vertically-integrated allergy care platform, today announced the grand opening of its flagship Nectar Allergy Center , located in New York City.

Key Points: 
  • Nectar Life Sciences , the trusted health technology company behind the first hybrid, vertically-integrated allergy care platform, today announced the grand opening of its flagship Nectar Allergy Center , located in New York City.
  • Nectar’s care offerings are now expanding from environmental allergies to more complex allergic conditions, including asthma, food allergies, and eczema.
  • Dr. Akansha Ganju, M.D., has also joined the company as Medical Director of the Nectar Allergy Center.
  • Increasing accessibility to comprehensive allergy care is a core part of Nectar Life Sciences’s mission, so the Allergy Center is strategically located near many subway and bus stops.

Newsweek Ranks 10 Select Medical Inpatient Rehabilitation Hospitals Among Nation's Best Physical Rehab Centers

Retrieved on: 
목요일, 8월 24, 2023

Kessler Institute for Rehabilitation - West Orange, Saddle Brook & Chester - #1

Key Points: 
  • Kessler Institute for Rehabilitation - West Orange, Saddle Brook & Chester - #1
    Cleveland Clinic Rehabilitation Hospital - Avon, Beachwood & Copley/Edwin Shaw* - #2
    Editor's Note:  All hospitals represent joint venture partnerships between Select Medical and the health system named with the exception of California Rehabilitation Institute which is a three-partner joint venture between Select Medical, Cedars Sinai and UCLA Health; and, Kessler Institute for Rehabilitation which is wholly owned by Select Medical.
  • Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider, examined physical rehabilitation centers from every U.S. state.
  • This year Newsweek awarded 280 inpatient facilities, based on the results of an online survey of over 4,400 experts on physical rehabilitation.
  • More information about the ranking criteria and methodology can be found here .

Los Angeles Celebrities and Philanthropists Raise Enough Funds to Provide the Equivalent of 1 Million Meals in Partnership with the Los Angeles Regional Food Bank

Retrieved on: 
목요일, 8월 17, 2023

LOS ANGELES, Aug. 17, 2023 /PRNewswire/ -- The Los Angeles Regional Food Bank hosted its 2nd Annual "A Million Reasons" Fundraising Event on the evening of Sunday, August 13, in a private home in the Hollywood Hills.

Key Points: 
  • LOS ANGELES, Aug. 17, 2023 /PRNewswire/ -- The Los Angeles Regional Food Bank hosted its 2nd Annual "A Million Reasons" Fundraising Event on the evening of Sunday, August 13, in a private home in the Hollywood Hills.
  • Proceeds of the evening will provide more than 1,000,000 meals for those facing food insecurity in Los Angeles County.
  • Among the night's highlights was an exclusive performance by the legendary Gladys Knight - the iconic singer known as the "Empress of Soul."
  • "The funds raised will help to provide more than one million meals to people in LA County, bringing hope and nourishment to our community during these challenging times."

Nike Basketball 3ON3 Tournament Extends Registration Deadline Until Friday at Midnight and Announces Event Sponsors

Retrieved on: 
금요일, 7월 28, 2023

Less than a week until tip-off of California’s largest outdoor 3-on-3 basketball tournament returning to L.A. LIVE’s Peacock Place from August 5-6, the Nike Basketball 3ON3 Tournament has today announced an extended registration deadline.

Key Points: 
  • Less than a week until tip-off of California’s largest outdoor 3-on-3 basketball tournament returning to L.A. LIVE’s Peacock Place from August 5-6, the Nike Basketball 3ON3 Tournament has today announced an extended registration deadline.
  • Teams can now register to compete in the tournament from now until Friday, July 28th at midnight.
  • View the full release here: https://www.businesswire.com/news/home/20230728718173/en/
    Nike Basketball 3ON3 Tournament returns to L.A. LIVE this August 5-6.
  • (Photo: Business Wire)
    Official sponsors of the Nike Basketball 3ON3 Tournament have also been announced for this year’s event including Nike Basketball who will return as the presenting partner of the competition and as the presenting partner for the Elite Division, Teen Division, and the Slam Dunk Contest for the 11th year.

New Luna study: Physical therapy patients prefer in-person, in-home care over virtual or facility-based care

Retrieved on: 
화요일, 7월 25, 2023

NASHVILLE, Tenn. , July 25, 2023 /PRNewswire/ -- Despite record investments in virtual physical therapy companies, most notably Hinge Health and Sword Health, a new study shows that physical therapy patients materially prefer hands-on, home-based care.

Key Points: 
  • NASHVILLE, Tenn. , July 25, 2023 /PRNewswire/ -- Despite record investments in virtual physical therapy companies, most notably Hinge Health and Sword Health, a new study shows that physical therapy patients materially prefer hands-on, home-based care.
  • Conducted by Luna , a leading provider of physical therapy, the study shows a strong preference for in-person, in-home care (5.0), with a reasonable willingness to use facility-based care (3.1) and, less desirable, virtual-based care (2.7) among under 55 age patients.
  • Consistent trends were observed among those for 55+ age patients: in-home care (5.0), facility-based care (2.8), and virtual-based care (1.9).
  • Unlike remote or virtual care, Luna's licensed physical therapists provide 1:1 hands-on care in the convenience of the patient's home.